Combination product of a bcl-2/bcl-xl inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases
US-2026053815-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Yang Dajun patents
Yang Dajun is listed as an inventor on 64 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Yang Dajun |
| Total patents | 64 |
| First publication | Jul 16, 2020 |
| Latest publication | Feb 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for cancer therapy
US-12544370-B2 · Feb 10, 2026 · US
Pharmaceutical combination and use thereof
US-12514863-B2 · Jan 6, 2026 · US
N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors
US-2025281511-A1 · Sep 11, 2025 · US
Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases
US-12370197-B2 · Jul 29, 2025 · US
Pharmaceutical Combination and Use Thereof
US-2025235426-A1 · Jul 24, 2025 · US
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors
US-12343352-B2 · Jul 1, 2025 · US
Combination of immunotherapies with mdm2 inhibitors
US-2025195473-A1 · Jun 19, 2025 · US
Methods for treating immune diseases
US-2025152580-A1 · May 15, 2025 · US
Method and compositions for predicting anti-cancer efficacy of compounds targeting apoptosis pathway
US-12287338-B2 · Apr 29, 2025 · US
Recent patents
Latest publications not already listed above.
Methods for treating aml-mrc and mds
US-2025114329-A1 · Apr 10, 2025 · US
Combination of immunotherapies with MDM2 inhibitors
US-12268665-B2 · Apr 8, 2025 · US
A pharmaceutical combination and use thereof
US-2025099440-A1 · Mar 27, 2025 · US
Pharmaceutical combination and use thereof
US-12233047-B2 · Feb 25, 2025 · US
Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating disease
US-12194024-B2 · Jan 14, 2025 · US
Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule
US-12186304-B2 · Jan 7, 2025 · US
Combination of bcl-2/bcl-xl inhibitors and chemotherapeutic agent and use thereof
US-2024390401-A1 · Nov 28, 2024 · US
Methods of treating a disease or disorder
US-2024366611-A1 · Nov 7, 2024 · US
Methods of treating multiple sclerosis
US-2024316069-A1 · Sep 26, 2024 · US
A pharmaceutical combination and use thereof
US-2024316051-A1 · Sep 26, 2024 · US
Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereof
US-12083136-B2 · Sep 10, 2024 · US
Methods for cancer therapy
US-2024122921-A1 · Apr 18, 2024 · US
MDM2 inhibitor and a platinum compound for cancer treatment
US-11850239-B2 · Dec 26, 2023 · US
Combination Therapies for Treating Cancer
US-2023404998-A1 · Dec 21, 2023 · US
Compositions and methods for treating non-alcoholic steatohepatitis
US-2023398110-A1 · Dec 14, 2023 · US
A pharmaceutical composition and use thereof for treatment of cancer
US-2023381176-A1 · Nov 30, 2023 · US
Compositions and methods for treating systemic lupus erythematosus
US-2023301989-A1 · Sep 28, 2023 · US
Microsuspension of an mdm2 inhibitor and therapeautic applications thereof
US-2023218575-A1 · Jul 13, 2023 · US
Novel medical use of mdm2 inhibitors
US-2023149356-A1 · May 18, 2023 · US
Methods for Treating Coronavirus Infections
US-2023078120-A1 · Mar 16, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ascentage Pharma Suzhou Co Ltd | 63 |
| Ascentage Pharma Group Corp Ltd | 45 |
| Guangzhou Healthquest Pharma Co Ltd | 6 |
| Ascentage Pharma Suzhu Co Ltd | 1 |
| Ascentage Pharma Group Corp Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 55 |
| A61K45/06 | 44 |
| A61K31/496 | 39 |
| A61P35/02 | 34 |
| A61K31/407 | 32 |